Table 3.
Prevalent cases of breast cancer | Ever use of COCs | Breast cancer ever users | ||
---|---|---|---|---|
3,577,264 | 79.3 percent | 2,836,770 | ||
Adjusted estimate of cases if no use of COCs | 2,383,841 | 1.19 (1.14–1.26) | Relative risk (95 percent confidence interval) | |
Excess cases | 452,930 | |||
Annual cost per patient with breast cancer | US$22,127 | |||
Estimated total costs | US$10,021,975,916 |